Бикалутамид Тева 150 мг

国家: 以色列

语言: 俄文

来源: Ministry of Health

现在购买

有效成分:

BICALUTAMIDE 150 MG

可用日期:

TEVA PHARMACEUTICAL INDUST.LTD

ATC代码:

L02BB03

药物剂型:

TABLETS

给药途径:

PER OS

厂商:

TEVA PHARMACEUTICAL INDUSTRIES LTD

治疗组:

BICALUTAMIDE

疗效迹象:

In patients with locally advanced prostate cancer (T3-T4 any N M0 T1-T2 N+ M0) Bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. The management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.

授权日期:

2009-05-01

其他语言的文件

资料单张 资料单张 英文 24-08-2023
公众评估报告 公众评估报告 英文 30-09-2021
资料单张 资料单张 阿拉伯文 24-08-2023
资料单张 资料单张 希伯来文 08-06-2023